WallStreetZenWallStreetZen

NASDAQ: ORIC
Oric Pharmaceuticals Inc Stock Ownership - Who owns Oric Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oric Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard A. HeymanDirector2026-07-246,100$12.02
$73.32kSell
Richard A. HeymanDirector2026-07-247,000$12.02
$84.14kSell
Richard A. HeymanDirector2026-07-243,500$1.60
$5.60kBuy
Richard A. HeymanDirector2026-07-06300$12.00
$3.60kSell
Dominic PiscitelliChief Financial Officer2026-02-2452,000$13.51
$702.68kSell
Dominic PiscitelliChief Financial Officer2026-02-2452,000$4.36
$226.72kBuy
Richard A. HeymanDirector2026-01-163,200$12.01
$38.42kSell
Richard A. HeymanDirector2026-01-163,500$12.01
$42.02kSell
Pratik S. MultaniChief Medical Officer2025-12-1610,720$9.06
$97.12kSell
Jacob ChackoPRESIDENT AND CEO2025-12-1633,374$9.06
$302.37kSell

1 of 3

ORIC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORIC insiders and whales buy or sell their stock.

ORIC Shareholders

What type of owners hold Oric Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Nextech Invest Ltd6.91%7,162,637$96.70MInstitution
Ecor1 Capital LLC6.49%6,728,116$90.83MInstitution
Blackrock Inc5.77%5,984,552$80.79MInstitution
Viking Global Investors LP5.62%5,824,533$78.63MInstitution
Price T Rowe Associates Inc5.20%5,387,783$72.74MInstitution
Pfizer Inc5.19%5,376,344$72.58MInsider
Pfizer Inc4.61%4,780,401$64.54MInstitution
Peter Svennilson4.60%4,768,181$64.37MInsider
Sr One Capital Management LP4.36%4,514,929$60.95MInstitution
Alkeon Capital Management LLC4.35%4,504,096$60.81MInstitution

1 of 3

ORIC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORIC84.67%15.33%Net SellingNet Selling
ABSI71.40%28.60%Net BuyingNet Selling
LBRX78.33%21.67%Net Buying
AVBP80.88%19.12%Net Selling
XERS57.70%13.49%Net SellingNet Selling
View Top Biotech Stocks

Oric Pharmaceuticals Stock Ownership FAQ

Who owns Oric Pharmaceuticals?

Oric Pharmaceuticals (NASDAQ: ORIC) is owned by 115.15% institutional shareholders, 20.85% Oric Pharmaceuticals insiders, and 0.00% retail investors. Pfizer Inc is the largest individual Oric Pharmaceuticals shareholder, owning 5.38M shares representing 5.19% of the company. Pfizer Inc's Oric Pharmaceuticals shares are currently valued at $72.58M.

If you're new to stock investing, here's how to buy Oric Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.